An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen Health

Tirzepatide in San Diego: clinics and prices

In San Diego, tirzepatide is available by prescription as Zepbound for weight and sleep apnea or Mounjaro for type 2 diabetes; Zepbound self-pay costs $299 to $449 a month through LillyDirect as of Oct 17 2026 [1]. Medi-Cal ended coverage of GLP-1s for adult weight loss on Jan 1 2026, but medically necessary non-weight uses can still be covered [2].

Updated Oct 17, 2026By the Wellchosen Health editorial team

Medical review: pending. A licensed clinician has not yet reviewed this page.

Tirzepatide is a weekly dual GIP and GLP-1 receptor agonist made by Eli Lilly.

Zepbound self-pay
$299 to $449/month (Oct 17 2026) [1]
Diabetes, San Diego County
10.0% of adults [3]
Medi-Cal
Weight-loss coverage ended for adults Jan 1 2026 [2]
Population
1,406,106 [4]
License lookup
Medical Board of California [5]

See tirzepatide prices

Medi-Cal, Mounjaro and Zepbound

The Medi-Cal change applies to weight loss. KFF Health News reports that GLP-1 uses other than weight loss can still be covered when medically necessary, and members under 21 keep coverage [2]. Mounjaro is approved for type 2 diabetes [6]; Zepbound is approved for weight management and for moderate to severe sleep apnea in adults with obesity [7]. About 10.0% of San Diego County adults report diagnosed diabetes [3].

Paid placement, shown with a label. We do not rate or rank the sponsor.

Zepbound self-pay, dose by dose

LillyDirect, checked Oct 17 2026
DosePriceSource
2.5 mg$299[1]
5 mg$399[1]
7.5 to 15 mg, refilled within 45 days$449[1]
Mounjaro, list price per 28 days$1,112.16[9]
On Dec 1 2025 Lilly cut vial prices from $349, $499 and $499 to these levels [8]. More on tirzepatide cost.

Sleep apnea: a second reason to ask about Zepbound

FDA approved Zepbound for moderate to severe obstructive sleep apnea in adults with obesity on Dec 20 2024 [10]. In the label's sleep apnea trials, breathing events per hour fell by 25.3 and 29.3 on average versus about 5 on placebo at 52 weeks [11]. Coverage for the sleep apnea use can differ from coverage for weight loss, so ask your plan about it; see Zepbound insurance.

Getting it safely

  • Prescribers: primary care, endocrinology, sleep medicine, or online programs. Ask any local health system whether it prescribes tirzepatide and how it bills.
  • Check the license with the Medical Board of California [5].
  • Compounded tirzepatide is not FDA-approved; FDA counts more than 730 adverse event reports for it as of May 31 2026 [12]. See compounded tirzepatide.
  • Results: SURMOUNT-1 participants on 15 mg lost 20.9% of body weight on average at 72 weeks [13].

Label warnings

Thyroid C-cell tumor boxed warning; not for people with medullary thyroid carcinoma or MEN 2 in the family. Severe stomach pain that does not go away can mean pancreatitis. Tell your anesthesia team you take it before any procedure, because aspiration has been reported [11]. Call 911 for emergencies.

Other cities: Los Angeles, Las Vegas, Sacramento. Overview: tirzepatide, tirzepatide near me.

Questions people ask

How much is Zepbound in San Diego?

LillyDirect self-pay is $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5 to 15 mg when refilled within 45 days, as of Oct 17 2026 [1].

Does Medi-Cal cover Mounjaro for diabetes?

Medi-Cal ended GLP-1 coverage only for adult weight loss on Jan 1 2026; uses other than weight loss can be covered if medically necessary [2]. Check your plan's formulary.

Is Zepbound approved for sleep apnea?

Yes. Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity [7].

How do I check a tirzepatide prescriber in California?

Enter the prescriber's name in the Medical Board of California license search [5].

How many adverse events has FDA logged for compounded tirzepatide?

More than 730 reports as of May 31 2026, which FDA says is likely an undercount [12].

What diabetes rate does San Diego County have?

CDC PLACES estimates 10.0% of San Diego County adults had diagnosed diabetes in 2023 [3].

Sources

13 cited
  1. Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  2. California Medicaid ends coverage of GLP-1 weight loss drugs. KFF Health News, Jan 9, 2026.
  3. PLACES: County Data, San Diego County (2025 release, BRFSS 2023). CDC, 2023.
  4. QuickFacts: San Diego city, California. U.S. Census Bureau, 2025.
  5. Medical Board of California. State of California, Oct 17, 2026.
  6. Mounjaro label. DailyMed, National Library of Medicine, Aug 2026.
  7. Zepbound label. DailyMed, National Library of Medicine, Aug 2026.
  8. Lilly lowers Zepbound vial prices (press release). Eli Lilly and Company, Dec 1, 2025.
  9. Mounjaro FAQ. Eli Lilly and Company, Oct 17, 2026.
  10. FDA approves first medication for obstructive sleep apnea. U.S. Food and Drug Administration, Dec 20, 2024.
  11. Zepbound prescribing information (217806s050). U.S. Food and Drug Administration, Apr 2026.
  12. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
  13. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), Jun 4, 2022.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

See tirzepatide prices